COVID Study Supports Antiviral Use in Kidney Transplant Recipients

(MedPage Today) -- Kidney transplant recipients with COVID-19 who received remdesivir (Veklury) early had a lower risk of graft loss, a target trial emulation study found.
Compared with no remdesivir, initiation of the antiviral within 7 days...